Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 2 of 1212345...10...Last »

Six Biotechs Facing Key FDA Decisions in March

Investors and biotech insiders are waiting during March 2017 for the U.S. Food and Drug Administration to rule on six therapies that will impact the bottom line of the developers, according to an analysis by RTT News.

Read More »

Sanofi and Lonza to build new $285 million Swiss biologics facility

French drugmaker Sanofi and Swiss manufacturer Lonza will invest 270 million euros ($285 million) in a new large-scale biologics facility that will produce monoclonal antibodies by 2020, the two companies said.

Read More »

Pfizer subpoenaed in U.S. over patient assistance plans

Pfizer Inc. said it received subpoenas from the U.S. Attorney’s Office for the District of Massachusetts related to its support for organizations that provide financial help to Medicare patients.

Read More »

PhRMA Convenes Stakeholders to Discuss Value Assessments and New Ways to Pay for Medicines

Leaders across the health care continuum gathered yesterday in Washington, D.C., to discuss ways to improve payment and delivery systems in the private market and opportunities for producing and rewarding better value for patients.

Read More »

StarsInMyEyes – Adult control ios, Spy on texting with phone number

The screen biz sector continues to be willing to power 3D technology to combat net piracy lately partially within an try into theaters. It is only latest developments that have developed it possible to existing 3D to other devices like home TVs and convenient devices although the technology has been around for many years. 3D […]

Read More »

StarsInMyEyes – Adult control ios, Spy on texting with phone number

The screen biz sector continues to be willing to power 3D technology to combat net piracy lately partially within an try into theaters. It is only latest developments that have developed it possible to existing 3D to other devices like home TVs and convenient devices although the technology has been around for many years. 3D […]

Read More »

Cempra’s bacterial skin infection drug clears study

Cempra Inc. said its experimental oral drug to treat acute bacterial skin infections cleared a late-stage study.

Read More »

Novartis wins CHMP nod for cancer drug combo

Novartis’ drugs Tafinlar and Mekinist edged closer to approval in Europe to be used together against a type of lung cancer.

Read More »

Cheap Flying Instructions and Best Airfare Schools while in the Philippines- Aviation Education and Pilot

SAT Essay writing necessitates an exceptionally unique set of skills. Often pupils try and stop article composing in their own routine research class. Creating about what you think the entry personnel want to notice isn’t a fantastic idea both. There are numerous easy means for writing essays. They don’t find adequate moment to consider producing […]

Read More »

Surprising Departure: Celgene President and COO “Retiring” in the Summer

Jackie Fouse, president and chief operating officer of Celgene, will step down from her position on April 1, 2017 and remain with the company through June 30.

Read More »

Buyers Remorse: Merck & Co. Takes $2.9 Billion Charge on Hepatitis C Drug Inherited From $3.9 Billion Idenix Buy

Merck took a pre-tax $2.9 billion hit from its flagging hepatitis C drug candidate uprifosbuvir due to flagging sales in the market, in part due to the success of drugs already available, which would include Gilead Sciences’ Harvoni and Sovaldi treatments.

Read More »

Scientists test deep brain stimulation as potential anorexia therapy

A small study in 16 people with severe anorexia has found that implanting stimulation electrodes into the brains of patients could ease their anxiety and help them gain weight.

Read More »

Merck drug prevents serious infection after marrow transplant: study

An experimental Merck drug succeeded in preventing clinically serious cytomegalovirus following bone marrow transplant and was associated with a lower death rate compared with placebo.

Read More »

Boston Scientific recalls all Lotus Valve heart devices

Boston Scientific Corp. said the company was recalling its Lotus range of heart devices, citing reports of problems with the locking mechanism, sending its shares down 7.3 percent in morning trading.

Read More »

Depression top cause of disability, strikes young and old: WHO

More than 4 percent of the world’s population lives with depression, and women, youth and the elderly are the most prone to its disabling effects, the World Health Organization (WHO) said.

Read More »

Cyclacel’s leukemia drug fails in key study

Cyclacel Pharmaceuticals Inc. said its lead experimental drug did not help elderly patients with acute myeloid leukemia live longer in a late-stage study.

Read More »

The End of the Road: NovaDel Pharma to Dissolve

After taking more than a year to sell off its insomnia medication ZolipiMist to Amherst Pharmaceuticals, NovaDel Pharma has dissolved the company.

Read More »

Medical Advertising Hall of Fame 2017

Ryan Abbate and Mike Lazur were honored as the 2017 inductees for the Medical Advertising Hall of Fame black-tie event held on Feb. 22 at The Pierre Hotel in New York City.

Read More »

Roche Reports Death in Phase III Hemophilia Study

Swiss-based Roche reported a death in its ACE910 study of emicizumab in patients with hemophilia A and factor VIII inhibitors.

Read More »

Novartis cancer drug Zykadia gets FDA priority review

The U.S. Food and Drug Administration (FDA) has granted priority review to the Novartis drug Zykadia as a first-line treatment for some lung cancer patients, the Swiss drugmaker said.

Read More »

Page 2 of 1212345...10...Last »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

April 2018 Focus: Agency Profiles, Manny Awards and Annual Review

Subscribe

Ad Right Bottom

Main Navigation